Y-Intercept (HK)’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.36M Buy
+47,343
New +$1.32M 0.03% 902
2026
Q1
Sell
-88,905
Closed -$2.05M 2026
2025
Q4
$2.05M Buy
+88,905
New +$2.29M 0.05% 607
2025
Q1
Sell
-12,028
Closed -$292K 1588
2024
Q4
$292K Buy
+12,028
New +$343K 0.02% 942
2023
Q1
Sell
-16,560
Closed -$804K 1521
2022
Q4
$804K Buy
16,560
+3,308
+25% +$207K 0.12% 264
2022
Q3
$935K Buy
+13,252
New +$1.13M 0.09% 315
2022
Q1
Sell
-4,230
Closed -$386K 940
2021
Q4
$386K Buy
4,230
+887
+27% +$95.2K 0.09% 318
2021
Q3
$430K Buy
+3,343
New +$468K 0.08% 373

Other funds holding STAA

Y-Intercept (HK)'s STAA Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in STAAR Surgical (STAA) in Q2 2026: 47,343 shares worth $1.36M. The stake represents 0.03% of the portfolio and ranks #902 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in STAA as recently as Q4 2025.

Y-Intercept (HK) first reported a position in STAA in Q3 2021 and has held it in 7 quarters since. The position peaked at $2.05M in Q4 2025. 200 funds tracked by Wall St. Rank hold STAA as of Q2 2026.

  • Y-Intercept (HK) held 47,343 shares of STAAR Surgical worth $1.36M as of Q2 2026.
  • STAAR Surgical was a new Y-Intercept (HK) position in Q2 2026.
  • STAAR Surgical made up 0.03% of Y-Intercept (HK)'s portfolio in Q2 2026, its #902 holding.
  • Y-Intercept (HK) first reported a position in STAAR Surgical in Q3 2021 and has held it in 7 quarters since.
  • Y-Intercept (HK)'s STAAR Surgical position peaked at $2.05M in Q4 2025.
  • 200 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.